|
|
|
Volumn 7, Issue 11, 2004, Pages 1028-1034
|
|
Idraparinux sodium Sanofi-Aventis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIVITAMIN K;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
ENOXAPARIN;
FONDAPARINUX;
HEPARIN;
IDRAPARINUX;
LONG ACTING DRUG;
LOW MOLECULAR WEIGHT HEPARIN;
PENTASACCHARIDE;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
WARFARIN;
ANTICOAGULANT THERAPY;
ARTICLE;
BLEEDING;
BLOOD CLOT LYSIS;
BLOOD CLOTTING TIME;
CLINICAL TRIAL;
CROHN DISEASE;
DEEP VEIN THROMBOSIS;
DRUG METABOLISM;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
LIVER TOXICITY;
LUNG EMBOLISM;
NONHUMAN;
PARTIAL THROMBOPLASTIN TIME;
PATENT;
STROKE;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTE ACTIVATION;
THROMBOEMBOLISM;
ANIMALS;
CLINICAL TRIALS;
FIBRINOLYTIC AGENTS;
HUMANS;
OLIGOSACCHARIDES;
STRUCTURE-ACTIVITY RELATIONSHIP;
THROMBOSIS;
|
|
EID: 9944251352
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (23)
|
|
References (0)
|
